会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 58. 发明申请
    • PARTICLE AGGLUTINATION DETECTION METHOD AND DEVICE
    • 粒子分离检测方法和装置
    • WO2005003787A1
    • 2005-01-13
    • PCT/IL2004/000618
    • 2004-07-08
    • INVERNESS MEDICAL SWITZERLAND GMBHROTT, GennadySAMUELS, FredFISH, Falk
    • ROTT, GennadySAMUELS, FredFISH, Falk
    • G01N33/80
    • G01N33/80
    • Abstract A method for the detection and/or visualization of particle agglutination, comprising: placing a volume of a suspension of the particles on a filter, the filter being constructed so as to permit passage of individual particles; placing a volume of a solution or suspension containing an agglutinating agent at the location of the particle suspension; optionally placing a wash solution at the location of the agglutinating agent; and observing the surface at the location for the presence of particles, such presence indicating that agglutination of the particles occurred. There is also provided a method for detection of agglutination reactions in general and hemagglutination reactions, such as used in blood grouping and cross-matching, in particular. The method is comprised of successive vertical additions of whole blood, blood grouping reagent and wash to a filter. In case of hemagglutination a colored, preferably red or reddish dot becomes visible after washing. A device and a kit based on the invention is also claimed and facilitates blood grouping and matching in non-laboratory environment without the need for laboratory instruments.
    • 摘要一种用于检测和/或可视化颗粒凝集的方法,包括:将一定体积的颗粒悬浮液放置在过滤器上,所述过滤器构造成允许单个颗粒通过; 将一定体积的含有凝集剂的溶液或悬浮液放置在颗粒悬浮液的位置; 任选地将洗涤溶液置于凝集剂的位置; 并且在该位置处观察颗粒存在的表面,这种存在表明颗粒发生凝集。 还提供了一般检测凝集反应的方法,特别是用于血液分组和交叉匹配的血细胞凝集反应。 该方法包括连续垂直添加全血,血液分组试剂和洗涤过滤器。 在血细胞凝集的情况下,洗涤后可见有色的,优选的红色或微红色点。 还要求一种基于本发明的装置和试剂盒,并且在非实验室环境中便于血液分组和匹配,而不需要实验室仪器。
    • 59. 发明申请
    • BODILY FLUID MARKERS OF TISSUE HYPOXIA
    • 组织缺氧的体液标记物
    • WO2004046729A2
    • 2004-06-03
    • PCT/GB2003/005113
    • 2003-11-21
    • THE UNIVERSITY OF LEICESTERINVERNESS MEDICAL SWITZERLAND GMBHNG, Leong
    • NG, Leong
    • G01N33/68
    • G01N33/6893
    • The present invention provides a method and kit for screening, diagnosis or prognosis of tissue hypoxia or of a clinical syndrome indicative of tissue hypoxia in a mammalian subject, for determining the stage or severity of tissue hypoxia or of a clinical syndrome indicative of tissue hypoxia in a mammalian subject, for identifying a mammalian subject at risk of developing tissue hypoxia or a clinical syndrome indicative of tissue hypoxia, or for monitoring the effect of therapy administered to a mammalian subject having tissue hypoxia or a clinical syndrome indicative of tissue hypoxia. The level of oxygen regulated protein (ORP150) or a fragment thereof in a sample of bodily fluid from said mammalian subject is measured to provide information as regards the tissue hypoxia or clinical syndrome indicative of tissue hypoxia.
    • 本发明提供了用于筛选,诊断或预后哺乳动物受试者的组织缺氧或指示组织缺氧的临床综合征的方法和试剂盒,用于确定组织缺氧或者组织缺氧的阶段或严重程度 指示哺乳动物受试者中组织缺氧的临床综合征,用于鉴定处于发展中组织缺氧或指示组织缺氧的临床综合征的风险中的哺乳动物受试者,或用于监测施用于具有组织缺氧或临床的哺乳动物受试者的疗法的效果 综合征指示组织缺氧。 测量来自所述哺乳动物受试者的体液样品中氧调节蛋白(ORP150)或其片段的水平以提供关于组织缺氧或指示组织缺氧的临床综合征的信息。